Abstract Library

#4418 Endoscopic ultrasound-guided radiofrequency ablation is a safe and efficient treatment of symptomatic insulinomas – A single centre experience of 14 patients

Introduction: The vast majority of insulinomas are benign and less than 20 mm. Surgery is considered as standard treatment, but complications are significant. Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) represents a novel and minimally invasive approach.

Conference:

Presenting Author: Andreassen M

Authors: Andreassen M, Kovacevic B, Brink L, Hansen C, Knigge U,

Keywords: Insulinoma, Benign, EUS, radiofrequency ablation,

#3682 Endoscopic ultrasound-guided radiofrequency ablation of low-grade insulinomas

Introduction: Insulinomas are rare pancreatic neuroendocrine neoplasms that may cause significant symptoms and substantially reduce quality of life. In resectable patients, the current treatment recommendation is surgery with either enucleation or resection of all or parts of the gland. This treatment may be associated with high morbidity and long convalescence. Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) is a new and minimally invasive treatment for patients with insulinomas.

Conference:

Presenting Author: Andreassen M

Authors: Jansen C, Vilmann P, Brink L, Andreassen M, Knigge U,

Keywords: Insulinoma, Endoscopic ultrasound, RFA,

#3417 SARS-CoV-2 vaccination site as possible pitfall on somatostatin receptor imaging

Introduction: SARS-CoV-2 (COVID19) vaccinations have shown high efficacy. Therefore, increased chances exist that patients undergoing Peptide Receptor Radionuclide Therapy (PRRT) or radionuclide imaging for Neuroendocrine Tumors (NETs) may have being recently vaccinated.

Conference:

Presenting Author: Kolade O

Authors: Kolade O, Ayeni A, Brink A, Steyn R, Prasad V,

Keywords: COVID-19, SARS-CoV-2, Lu-177 DOTATATE, Ga-68 DOTANOC, Vaccination, PRRT, Neuroendocrine Tumor,